Study Aims
The primary goal of this study was to assess safety of the OIT protocol by analyzing the percentage of patients experiencing adverse effects during the up-dosing phase, documented at each appointment. Symptoms severity was assessed using the validated ordinal food allergy severity scale (O-FASS-5)21, with grade 1 reactions categorized as mild, grades 2-3 reactions as moderate, and grades 4- 5 as severe. Furthermore, we conducted additional analyses to assess the successful completion of the maintenance phase and to explore changes in immunological parameters.